10-Jan-2017 | Zion Market Research
Zion Market Research has published a new report titled “Calcium Channel Blocker Market by Drug class (Dihydropyridine and Non-Dihydropyridine) for Hypertension, Angina Pectoris, Pregnancy, Obesity and Other - Global Industry Perspective, Comprehensive Analysis and Forecast, 2016 – 2022”. According to the report, the global calcium channel blocker market accounted for USD 11.26 billion in 2016 and is expected to reach USD 15.31 billion, growing at a CAGR of around 5.4% between 2017 and 2022.
Calcium channel blockers are the chemical class of antihypertensive drugs used to treat various ill conditions of the heart and blood vessels. For example, CCB is commonly used in the treatment of angina pectoris, hypertension, and Reynaud’s phenomenon. Combination therapy is commonly used in the treatment of high blood pressure or angina pectoris.
Browse the full "Calcium Channel Blocker Market by Drug class (Dihydropyridine and Non-Dihydropyridine) for Hypertension, Angina Pectoris, Pregnancy, Obesity and Other - Global Industry Perspective, Comprehensive Analysis, Size, Share, Growth, Segment, Trends and Forecast, 2016 - 2022" report at https://www.zionmarketresearch.com/report/calcium-channel-blocker-market
Based on product, calcium channel blocker market is segmented into two types: Dihydropyridine and Non-Dihydropyridine. Dihydropyridine is one of the important groups of calcium channel blocker which held approximately 65%of the overall market in 2016. Dihydropyridineclass is expected to be the largest segment in the market due to growing demand from pharmaceutical industry.Lower cost and easy availability of the products is expected to propel the growth of Dihydropyridinesegment.Dihydropyridine class of CCB market is further sub-segmented into Amlodipine, Cilnidipine, Felodipine, Verapamil, Diltiazem, Isradipine, Nicardipine, Nisoldipine, Nifedipine, and others.Whereas, the Non-Dihydropyridine market is sub-segmented into Diltiazem and Verapamil.
Based on application, calcium channel blocker market segmented into five types: the calcium hypertension, angina pectoris, pregnancy, anti-obesity and other.Hypertension segment the calcium channel blocker market in 2016. For instance, in hypertensionVerapamil and Amlodipine are increasingly used in the pharmaceutical industry. Amlopdipine is a first line therapy for the treatment obesity, angina pectoris and others.
Based on geography, calcium channel blocker market segmented into five major regions: North America, Europe, Asia Pacific, Latin America and Middle East and Africa.North America accounted for the largest share in the market in terms of consumption.Rising percentage of obese and hypertension patient population in Asia Pacific is expected to prompt the growth of calcium channel blocker market within the forecast period.
The report covers detailed competitive outlook including the market share and company profiles of the key participants operating in the global calcium channel blocker which include Pfizer Inc., AstraZeneca Plc., bayer healthcare LLC., GlaxoSmithKline Plc., Sanofi S.A., Johnson & Johnson, Abcam, AbMole Bioscience, and Clearsynth.
This report segments the global Calcium channel blocker as follows:
Global Calcium Channel Blocker: Drug Type Segment Analysis
Global Calcium Channel Blocker: Application Type Segment Analysis
Global Calcium Channel Blocker: Regional Segment Analysis
Zion Market Research is an obligated company. We create futuristic, cutting edge, informative reports ranging from industry reports, the company reports to country reports. We provide our clients not only with market statistics unveiled by avowed private publishers and public organizations but also with vogue and newest industry reports along with pre-eminent and niche company profiles. Our database of market research reports comprises a wide variety of reports from cardinal industries. Our database is been updated constantly in order to fulfill our clients with prompt and direct online access to our database. Keeping in mind the client’s needs, we have included expert insights on global industries, products, and market trends in this database. Last but not the least, we make it our duty to ensure the success of clients connected to us—after all—if you do well, a little of the light shines on us.
Zion Market Research
4283, Express Lane,
Sarasota, Florida 34249, United States
Tel: +49-322 210 92714
USA/Canada Toll-Free No.1-855-465-4651
Technology & Media
Chemical & Materials
17-Jan-2017 | Medical Device
16-Jan-2017 | Chemical & Materials
16-Jan-2017 | Technology & Media
16-Jan-2017 | Automotive
16-Jan-2017 | Food & Beverage